GB875164A - New hydroxyflavones, their production and use as anti-oxidants - Google Patents

New hydroxyflavones, their production and use as anti-oxidants

Info

Publication number
GB875164A
GB875164A GB24031/56A GB2403156A GB875164A GB 875164 A GB875164 A GB 875164A GB 24031/56 A GB24031/56 A GB 24031/56A GB 2403156 A GB2403156 A GB 2403156A GB 875164 A GB875164 A GB 875164A
Authority
GB
United Kingdom
Prior art keywords
groups
positions
hydroxy
alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24031/56A
Inventor
Thomas Hardy Simpson
Norbert Uri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Priority to GB24031/56A priority Critical patent/GB875164A/en
Publication of GB875164A publication Critical patent/GB875164A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021Preserving by using additives, e.g. anti-oxidants containing oxygen
    • C11B5/0035Phenols; Their halogenated and aminated derivates, their salts, their esters with carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises (a) 7-alkyl ether derivatives of 3:7:21:51-tetrahydroxyflavone, which may be substituted at one or more of the 5-, 6-, 8-, 31-, 41- and 61- positions by alkyl groups and which have alkoxy or aralkoxy groups in place of the hydroxy groups in the 21- and 51- positions; (b) 3:7:21:51-tetra hydroxyflavone derivatives substituted at the 5-, 6-, 8-, 31-, 41-, and 61- positions by one o more alkyl groups; and (c) 3:7:8:21:51-pentahydroxyflavone and 7- and/or 8- and/or 21-and/or 51-alkyl ether derivatives thereof which may be substituted at the 5-, 6-, 31-, 41-, and 61- positions by one or more alkyl groups, together with their preparation by oxidising a chalkone of the general formula:- <FORM:0875164/IV (b)/1> <FORM:0875164/IV (b)/2> wherein X and/or X1 are protecting groups (e.g. benzyl, isopropyl or methyl) which can subsequently be removed or are hydrogen atoms, R is alkoxy and R1 is hydrogen, alkyl, or alkoxy, and any unoccupied position in either ring may be substituted by alkyl, and thereafter if necessary removing the protecting groups and/or converting R and R1 into hydroxy groups. The oxidation is preferably carried out with alcoholic potassium hydroxide and hydrogen peroxide, and the protecting groups may be removed by treatment with HCl or HBr and acetic acid or HI and phenol. In Examples:- (1) gentisaldehyde is benzylated and the dibenzyl ether condensed with 2-hydroxy-4-methoxyacetophenone in aqueous ethanolic alkali giving 2,5-bis(benzyloxy)-21-hydroxy-41-methoxy chalkone, which is oxidised with H2O2 in alcoholi KOH to 21,51-bis (benzyloxy)-3 - hydroxy - 7 - methoxy flavone, characterized as its acetate, and debenzylated with HCl-acetic acid to 3,21,51-trihydroxy-7-methoxyflavone; (2) 2,5-bis(benzyloxy)-41-n-butoxy-2-hydroxychalkone prepared as in (1) is oxidised and debenzylated to 7-n-butoxy-3,21,51-trihydroxyflavone, characterized as its 7,8-dimethoxyflavone is refluxed with aqueous HBr giving 3,7,8,21,51-pentahydroxyflavone; (4) paenol is condensed with 2-hydroxy-5-methoxybenzaldehyde and the resulting chalkone oxidised to 3,21-dihydroxy-7,51-dimethoxyflavone; (5) resacetophenone is monoetherified with cetyl bromide and condensed with 2,5-dibenzyloxybenzaldehyde, the chalkone oxidised with H2O2 and debenzylated to 7-cetyloxy-3,2151-trihydroxyflavone, characterized as its triacetate; (6) 5 - ethyl - 2,4 - dihydroxyacetophenone is monomethylated and then treated as in (4) giving 3,21-dihydroxy-7,51-dimethoxy-6-ethylflavone and its diacetate; (7) demethylation yields 6-ethyl-3,7,21,51-tetrahydroxyflavone; (8) and (9), 3,4-dimethoxy-5-ethyl-2-hydroxyacetophenone and 5 - n - hexyl - 2 - hydroxy-4-methoxyacetophenone similarly give 6-ethyl-3,7,8,21,51-pentahydroxyflavone and 6-n-hexyl-3,7,21,51-tetrahydroxyflavone respectively; (10) O-benzylhydroquinone is treated with chloroform and alkali giving 5-benzyloxy-2-hydroxybenzaldehyde, which is methylated and condensed with 2-hydroxy-3,4-dimethoxy-5-stearylacetophenone (prepared from pyrogallol by treatment with stearic acid and BF3, reduction of the resulting 2,3,4-trihydroxystearophenone, C-acetylation with BF3 of the 4-stearylpyrogallol and methylation of the 2,3,4-trihydroxystearylacetophenone) giving a chalkone which on oxidation yields 3,51-dihydroxy-7,8,21-trimethoxy-6-stearylflavone and is then demethylated with HI in phenol; (11) 3,7,21,51-tetrahydroxy-6-stearyl flavone is similarly obtained; (12) 2-hydroxy-3,4-dimethoxyacetophenone and dibenzylgentisaldehyde as in (1) yield 3,21,51-trihydroxy-7,8-dimethoxyflavone.ALSO:Fatty oils, fats and other liquids subject to oxidative rancidity are protected against oxidation by the incorporation therein of a small proportion of one or more hydroxy flavones selected from the following:-(a) 7-alkyl ethers of 3:7:21:51-tetrahydroxyflavone, which may be substituted at one or more of the 5-, 6-, 8, 31, 41, and 61- positions by alky groups and which may have alkoxy or aralkoxy groups in place of the hydroxy groups in the 21- and 51- positions; (b) 3:7:21:51-tetrahydroxyflavone derivatives substituted at the 5-, 6-, 8-, 31, 41, and 61- positions by one or more alkyl groups; (c) 3:7:8:21:51-pentahydroxyflavone and 7- and/or 8- and/or 21-and/or 51- alkyl ether derivatives thereof which may be substituted at the 5-, 6-, 31-, 41-, and 61- positions by one or more alkyl groups. A table gives the anti-oxidant efficiencies of twenty-two flavones (including known compounds) in linoleic acid, methyl linoleate, their aqueous emulsions and benzene solutions using cobaltous stearate and ferrous phthalocyanine as catalysts.ALSO:Lipid-containing foods and feeds are protected against oxidative rancidity by the incorporation of a small proportion of one or more of the hydroxyflavones: (a) 7-alkyl ethers of 3 : 7 : 21 : 51 - tetrahydroxyflavone, which may be alkyl substituted at positions 5, 6, 8, 31, 41 or 61, and which may have alkoxy or aralkoxy groups in place of hydroxy groups at 21 and 51 positions; (b) 3 : 7 : 21 : 51 - tetrahydroxyflavones substituted at the 5, 6, 8, 31, 41 or 61 positions by one or more alkyl groups; (c) 3 : 7 : 8 : 21 : 51 - pentahydroxyflavone and its 7 and/or 8 and/or 21 and/or 51 alkyl ether derivatives, which may be substituted at 5, 6, 31, 41 or 61 positions by one or more alkyl groups. The flavones may be incorporated during cooking in food manufacture.
GB24031/56A 1956-08-03 1956-08-03 New hydroxyflavones, their production and use as anti-oxidants Expired GB875164A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB24031/56A GB875164A (en) 1956-08-03 1956-08-03 New hydroxyflavones, their production and use as anti-oxidants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24031/56A GB875164A (en) 1956-08-03 1956-08-03 New hydroxyflavones, their production and use as anti-oxidants

Publications (1)

Publication Number Publication Date
GB875164A true GB875164A (en) 1961-08-16

Family

ID=10205285

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24031/56A Expired GB875164A (en) 1956-08-03 1956-08-03 New hydroxyflavones, their production and use as anti-oxidants

Country Status (1)

Country Link
GB (1) GB875164A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031430A2 (en) * 2001-10-04 2003-04-17 Brane Tech S.R.L. Flavonoid compounds and their pharmaceutical uses
CN111303105A (en) * 2019-04-19 2020-06-19 武汉万知化工医药有限公司 Preparation method of 7, 8-dihydroxyflavone
CN114052247A (en) * 2020-08-06 2022-02-18 晨光生物科技集团股份有限公司 An antioxidant composition containing quercetagetin, 6-hydroxy kaempferol and gallic acid

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031430A2 (en) * 2001-10-04 2003-04-17 Brane Tech S.R.L. Flavonoid compounds and their pharmaceutical uses
WO2003031430A3 (en) * 2001-10-04 2004-04-08 Brane Tech S R L Flavonoid compounds and their pharmaceutical uses
CN111303105A (en) * 2019-04-19 2020-06-19 武汉万知化工医药有限公司 Preparation method of 7, 8-dihydroxyflavone
CN114052247A (en) * 2020-08-06 2022-02-18 晨光生物科技集团股份有限公司 An antioxidant composition containing quercetagetin, 6-hydroxy kaempferol and gallic acid
CN114052247B (en) * 2020-08-06 2023-06-16 晨光生物科技集团股份有限公司 An antioxidant composition containing quercetin, 6-hydroxy kaempferol and gallic acid

Similar Documents

Publication Publication Date Title
Fetizon et al. Oxidations with silver carbonate/celite. V. Oxidations of phenols and related compounds
MX167397B (en) PROCEDURE FOR THE PREPARATION OF FURO DERIVATIVES- (3,4-c) -PIRIDINE
EP0044260A3 (en) Process for the preparation of polyphenols optionally substituted by an aldehyde group
Nagem et al. Xanthones and other constituents of Vismia parviflora
GB875164A (en) New hydroxyflavones, their production and use as anti-oxidants
WANASUNDARA et al. Stabilization of marine oils with flavonoids
Ogawa et al. Hydroxybenzoquinones from Myrsinaceae plants. III. The structures of 2-hydroxy-5-methoxy-3-pentadecenylbenzoquinone and Ardisiaquinones A, B and C from Ardisia spp.
US3064012A (en) Derivatives of coenzyme q10
US3118914A (en) Isoprenoid substituted quinones of the coenzyme q type
GB1040176A (en) Chromanols and their derivatives
DE3568978D1 (en) Process for producing aromatic diols and their ester and ether derivatives
JPS56142236A (en) Ml-236a and mb-530a derivative
Vleggaar et al. Flavonoids from Tephrosia—IX: the structure of multijugin and multijuginol
Miller et al. Antioxidant activity of phenols as related to effects of substituent groups
GB949715A (en) Improvements in or relating to chromanols
Lee et al. Synthesis of linderone and methyl-inderone
Olivella et al. A comparative study of bacteriostatic activity of synthetic hydroxylated flavonoids
Nakano et al. Isoflavonoids of the bark of Dipteryx odorata Willd.(Aubl.)
Schall et al. The antioxidants of the Osage orange fruit
Anderson et al. 2, 3-Dihydro-2, 3-dihydroxybenzoquinone dimer
Ronald et al. Total synthesis of frustulosin
ES404787A1 (en) Substituted xanthone carboxylic acid compounds
Bentley et al. Novel analgesics and molecular rearrangements in the morphine–thebaine group. Part XI. The base-catalysed rearrangement of dihydrothebainequinone
Row et al. Isolation of (+) O-pentamethyl dihydromelanoxetin from albizzia odoratissima Benth.
Church et al. A novel approach to a key intermediate in the total synthesis of [alpha]-onocerin